Deletion of the CYP2D6 gene as a likely explanation for the serious side effects of the antipsychotic drug pimozide: a case report
CYP2D6 analysis prior to the prescription of pimozide is required above a certain dose by the Food and Drug Administration in order to detect individuals with the poor metabolizer status. This precautionary measure aims to prevent the occurrence of serious adverse drug reactions. This study presents...
Saved in:
Main Authors: | Fernando Facal (Author), Begoña Portela (Author), Almudena Gil-Rodríguez (Author), Francisco Barros (Author), Olalla Maroñas (Author), Angel Carracedo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics
by: Francisco José Toja-Camba, et al.
Published: (2021) -
Minisequencing mitochondrial DNA pathogenic mutations
by: Carracedo Ángel, et al.
Published: (2008) -
Developments in pharmacogenetics, pharmacogenomics, and personalized medicine
by: Francisco Abad-Santos, et al.
Published: (2024) -
Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon
by: Fernandes MR, et al.
Published: (2021) -
Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration
by: Laura García-Quintanilla, et al.
Published: (2019)